Literature DB >> 9511805

Physiological and pathological factors of human breast disease that can influence optical diagnosis.

S Thomsen1, D Tatman.   

Abstract

The 'normal' human female breast is a very complex organ that changes considerably during development, pregnancy and menopause. In addition, it is an excretory organ that, during lactation, discharges various metabolites and certain drugs that can be optically active. Optical diagnosis of breast cancers requires detection of differential concentrations of 1) various absorbers and scatterers or 2) native or exogenous fluorophores to distinguish cancers from surrounding 'normal' and benign breast tissues. The differential concentrations are due to the biology of the cancer cells and the host responses to the cancer growth. For most patients, the cancer will be intermixed with a complex 3-dimensional array of 'normal' breast tissue and benign breast lesions. This complexity will challenge the optical biopsy investigator but, with the recent advances in our understanding of light transport, optical diagnostic techniques and devices can be developed to complement and supplement current breast cancer screening techniques.

Entities:  

Mesh:

Year:  1998        PMID: 9511805     DOI: 10.1111/j.1749-6632.1998.tb08197.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  24 in total

Review 1.  Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy.

Authors:  B J Tromberg; N Shah; R Lanning; A Cerussi; J Espinoza; T Pham; L Svaasand; J Butler
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography.

Authors:  Subhadra Srinivasan; Brian W Pogue; Shudong Jiang; Hamid Dehghani; Christine Kogel; Sandra Soho; Jennifer J Gibson; Tor D Tosteson; Steven P Poplack; Keith D Paulsen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-26       Impact factor: 11.205

3.  Anthropomorphic breast phantoms with physiological water, lipid, and hemoglobin content for near-infrared spectral tomography.

Authors:  Kelly E Michaelsen; Venkataramanan Krishnaswamy; Adele Shenoy; Emily Jordan; Brian W Pogue; Keith D Paulsen
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

4.  Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography.

Authors:  Ben Brooksby; Brian W Pogue; Shudong Jiang; Hamid Dehghani; Subhadra Srinivasan; Christine Kogel; Tor D Tosteson; John Weaver; Steven P Poplack; Keith D Paulsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

Review 5.  Advances in optical spectroscopy and imaging of breast lesions.

Authors:  Stavros G Demos; Abby J Vogel; Amir H Gandjbakhche
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

6.  A simulation study of the variability of indocyanine green kinetics and using structural a priori information in dynamic contrast enhanced diffuse optical tomography (DCE-DOT).

Authors:  Mehmet Burcin Unlu; Ozlem Birgul; Gultekin Gulsen
Journal:  Phys Med Biol       Date:  2008-05-27       Impact factor: 3.609

7.  Optical mammography: Diffuse optical imaging of breast cancer.

Authors:  Kijoon Lee
Journal:  World J Clin Oncol       Date:  2011-01-10

8.  Diffuse Optics for Tissue Monitoring and Tomography.

Authors:  T Durduran; R Choe; W B Baker; A G Yodh
Journal:  Rep Prog Phys       Date:  2010-07

Review 9.  Optical tomography of breast cancer-monitoring response to primary medical therapy.

Authors:  Louise C Enfield; Adam P Gibson; Jeremy C Hebden; Michael Douek
Journal:  Target Oncol       Date:  2009-09-24       Impact factor: 4.493

10.  Fluorescence spectroscopy: an adjunct diagnostic tool to image-guided core needle biopsy of the breast.

Authors:  Changfang Zhu; Elizabeth S Burnside; Gale A Sisney; Lonie R Salkowski; Josephine M Harter; Bing Yu; Nirmala Ramanujam
Journal:  IEEE Trans Biomed Eng       Date:  2009-03-04       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.